Wall Street Journal is reporting on Friday’s page A9 that a clinical trial is being run at the University of Toronto to see if a component of “Fish Oil”, the Omega-3 oil known by its initials EPA, and sold in highly purified form as the Amarin Inc. made prescription drug Vascepa, can treat COVID-19 Virus by reducing inflammation and protecting the inner layer of blood vessels known as the Endothelium.